MGMT and neoplasm: We have examined the effect of the modified guanine base, O6-(4-bromothenyl)guanine (PaTrin-2, PatrinTM, Lomeguatrib) on MGMT activity and cell or xenograft tumour growth inhibition by temozolomide in the human breast carcinosarcoma cell line, MCF-7.